The TPHA (Treponema Pallidum Hemagglutination Assay) test is a confirmatory blood test used to detect antibodies against Treponema pallidum, the bacterium responsible for syphilis. It works by identifying specific antibodies that cause red blood cells coated with treponemal antigens to clump together (hemagglutination). The test is highly specific and is often performed after initial screening tests like VDRL or RPR. Its purpose is to confirm syphilis infection, rule out false positives, and guide appropriate treatment decisions for affected patients.
It confirms syphilis infection after initial screening tests like VDRL or RPR, ensuring accurate diagnosis.
Patients with positive syphilis screening results or unexplained symptoms suggestive of syphilis are recommended for testing.
A positive result confirms syphilis infection, guiding doctors to initiate appropriate antibiotic treatment.
A negative result suggests no syphilis infection, though very early stages may not be detected.
No, medications generally do not interfere with antibody detection in this test.
Without testing, syphilis may remain undiagnosed, leading to serious complications like neurological or cardiovascular damage.
It is usually performed once for confirmation, unless re-testing is needed for monitoring or unclear results.
Yes, through safe sexual practices, regular screening, and early treatment of infections.
Positive results confirm syphilis, which can affect multiple organs if untreated.
RPR/VDRL are screening tests, while TPHA is a specific confirmatory test for syphilis.
...
Didn't recieved OTP Yet? Resend OTP